Preblud SR, Orenstein WA, Bart KJVaricella: clinical manifestations, epidemiology and health impact in children . Pediatr Infect Dis J1984; 3:505-9.
2.
Bullowa Jgm, Wishik SM: Complications of varicella: their occurrence among 2,534 patients . AJDC1935; 49:923-32.
3.
Feldman SF, Hughes WT, Daniel CB: Varicella in children with cancer: seventy-seven cases. Pediatr1975; 56:388-99.
4.
Fleisher G., Henry W., McSorley M., et al. Life-threatening complications of varicella. AJDC1981; 135:896-9.
5.
Wade NA, Lepow ML, Veazey J., et al. Progressive varicella in three patients with Wiskott-Aldrich syndrome: treatment with adenine arabinoside. Pediatr1985; 75:672-5.
6.
Biron CA, Byron KS, Sullivan JLSevere herpes virus infections in an adolescent without natural killer cells . N Engl J Med1989; 320:1731-5.
7.
Jura E., Chadwick EG, Josephs SH, et al. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J1989; 8:586-90.
8.
Ameborn P., Biberfeld G.: T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun1983; 39:29-37.
9.
Cunningham-Rundles C.Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol1989; 9:22-33.
10.
Hausser C., Virelizier JL, Buroit D., et al. Common variable hypogammaglobulinemia in children. AJDC1983; 137:833-7.
11.
Arvin AM, Koropchak CM, Williams Brj, et al. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis1986; 154:422-9.
12.
Stiehm ERStandard and special human immune serum globulins as therapeutic agents . Pediatr1979; 63:301-19.
13.
Nyerges G., Meszner Z., Gyarmati E., et al. Acyclovir prevents dissemination of varicella in immunocompromised children. J Infect Dis1988; 157:309-13.
